Anil Grover, Head-Instruments and Reagents, Meril Diagnostics Pvt. Ltd.

Since its inception, Meril is dedicated toward design and development of novel, clinically relevant, state-of-the-art, and best-in-class medical devices. Meril's broad operational wingspan extends from vascular interventional devices to orthopedics, in vitro diagnostics, and endo-surgery.

Meril Diagnostics caters the complete range of analyzers as well as reagents for clinical biochemistry, hematology, immunology (ELISA and CLIA), critical care, diabetes management, coagulation, and lab consumables. The company is moving ahead in the direction of becoming an industry leader with indigenously developed range of products.

Meril works with the vision and mission of bringing significant difference to human lives, alleviate human suffering, and improve the quality of life while serving the healthcare. The company thus has a strong commitment toward R&D and adherence to best quality standards in manufacturing, scientific communication, and distribution known today.

India has witnessed the high-end technology revolution and still more than half the Indian IVD market's requirements are fulfilled by non-Indian companies. Meril Diagnostics' future plans include manufacturing of 80 percent of its products in India and catering them worldwide. The company's strategy of manufacturing analyzers and reagents is aptly supported by a team of highly qualified and experienced R&D personnel. The team commenced its projects in 2011 and launched several analyzers and reagents all Designed and developed by Meril'

Moving forward with the unification of research-empowered approach and the Make in India movement, Meril is committed to introduce novel, cost-effective indigenously developed technologies to serve the mankind. In this process, the company has created fully automated
i series of biochemistry analyzers with 100, 200, and 400 tests per hour throughput, designed and developed at its state-of-the-art manufacturing unit. Moreover, the company has also successfully developed AriQuant Series-compatible reagents for hematology and compatible system packs for biochemistry, which have been widely accepted in the market.

In its quest for innovation, Meril has been successful in completing the in-house development of hematology and biochemistry analyzers, controls, and reagents. It is part of Meril's mission to create a definitive change in the way the world perceives the Indian IVD market as not just a consumer but also as a manufacturer, capable of supplying high-end products.

Meril aims to create world-class quality products indigenously and provide end-to-end total solutions to its existing and future customers. Furthermore, the company commits to emerge as an organization with highest ethics and social responsibility, creating a platform to support the development of the country, society, and the customers.

We are Meril and we work with the dedication to add more to life of people to reduce their sufferings and improve the quality of life.


Why is The Government So Bad at Health Care?

 

randox

Digital version